Press Coverage
Sofinnova Capital
Henrijette Richter discusses R&D in plenary at WuXi Global Forum
Related Deal lead
Henrijette RichterRelated Strategy
CapitalHenrijette Richter, managing partner at Sofinnova Partners, participated in the opening plenary panel discussion at the WuXi Global Forum 2022 on January 10. Marking the 10th anniversary of the event, the panel, led by Jorge Conde, general partner at Andreessen Horowitz, took a look back at 10 years of breakthroughs that are changing the game in R&D productivity before turning their focus on the future. Henrijette joined David Berry, founder and CEO of Valo Health; Diego Miralles, CEO of Laronde, and Roger Perlmutter, chairman and CEO of Eikon Therapeutics.
View the replay here.
Related News
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome
CorWave completes enrollment in feasibility study and presents first clinical data on adaptive support with its Wave Membrane LVAD
Muna Therapeutics announces positive Phase 1 results supporting potential of oral small-molecule TREM2 Modulator in Alzheimer’s disease
TISSIUM® receives CE Mark for ECLIPSIUM®, Its atraumatic hernia repair solution